Department of Infectious Diseases and Infection Control, Saitama International Medical Center, Saitama Medical University, 397-1, Hidaka, Saitama, 350-1298, Japan.
Department of Infectious Diseases and Infection Control, Saitama International Medical Center, Saitama Medical University, 397-1, Hidaka, Saitama, 350-1298, Japan.
J Infect Chemother. 2024 Dec;30(12):1259-1265. doi: 10.1016/j.jiac.2024.06.002. Epub 2024 Jun 12.
Infective endocarditis (IE) caused by MRSA (methicillin-resistant Staphylococcus aureus) is associated with a high mortality rate. This study aimed to elucidate the characteristics of patients with MRSA-IE in Japan and identify the factors associated with prognosis.
This retrospective study included patients with a confirmed diagnosis of IE caused by MRSA, between January 2015 and April 2019.
A total of 65 patients from 19 centers were included, with a mean age of 67 years and 26 % were female. Fifty percent of the patients with IE were had nosocomial infections and 25 % had prosthetic valve involvement. The most common comorbidities were hemodialysis (20 %) and diabetes (20 %). Congestive heart failure was present in 86 % of patients (NYHA class I, II: 48 %; III, IV: 38 %). The 30-day and in-hospital mortality rates were 29 % and 46 %, respectively. Multi-organ failure was the primary cause of death, accounting for 43 % of all causes of death. Prognostic factors for in-hospital mortality were age, disseminated intravascular coagulation, daptomycin and/or linezolid as initial antibiotic therapy, and surgery. Surgical treatment was associated with a lower mortality rate (odds ratio [OR], 0.026; 95 % confidence interval [CI], 0.002-0.382; p = 0.008 for 30-day mortality and OR, 0.130; 95 % CI; 0.029-0.584; p = 0.008 for in-hospital mortality).
Mortality due to MRSA-IE remains high. Surgical treatment is a significant prognostic predictor of MRSA-IE.
耐甲氧西林金黄色葡萄球菌(MRSA)引起的感染性心内膜炎(IE)死亡率较高。本研究旨在阐明日本 MRSA-IE 患者的特征,并确定与预后相关的因素。
这是一项回顾性研究,纳入了 2015 年 1 月至 2019 年 4 月期间确诊为 MRSA 引起的 IE 的患者。
共有来自 19 个中心的 65 名患者入选,平均年龄为 67 岁,26%为女性。50%的 IE 患者发生医院感染,25%的患者有心脏瓣膜假体感染。最常见的合并症为血液透析(20%)和糖尿病(20%)。86%的患者存在充血性心力衰竭(NYHA 心功能 I、II 级:48%;III、IV 级:38%)。30 天和住院死亡率分别为 29%和 46%。多器官衰竭是主要死亡原因,占所有死亡原因的 43%。住院死亡率的预后因素为年龄、弥散性血管内凝血、达托霉素和/或利奈唑胺作为初始抗生素治疗以及手术。手术治疗与较低的死亡率相关(30 天死亡率的优势比 [OR],0.026;95%置信区间 [CI],0.002-0.382;p=0.008;住院死亡率的 OR,0.130;95%CI,0.029-0.584;p=0.008)。
MRSA-IE 死亡率仍然较高。手术治疗是 MRSA-IE 的重要预后预测因素。